How Low Can Moderna Stock Go?
Moderna (NASDAQ: MRNA) is no longer the seemingly invincible, high-flying stock that it once was. Its shares are now close to 30% down from the high set in early August. And that reflects a bit of a rebound over the last few days.
There are plenty of reasons why the vaccine stock has lost some of its mojo. But my purpose here isn't to delve into why Moderna's share price has fallen from its soaring heights. I'd like to focus on the future rather than the past. To me, there's a much more important question to attempt to answer: How low can Moderna stock actually go?
Image source: Getty Images.
Source Fool.com
